Polymarket Raises $300M From Trump Jr.'s 1789 Capital as Regulatory Fight Intensifies

Polymarket has raised $300 million from 1789 Capital, an investment fund where Donald Trump Jr. serves as a partner, according to a Wall Street Journal report citing unnamed sources. The infusion is part of a broader funding round the Journal pegs at roughly $1 billion. Polymarket has not confirmed the figures publicly, and TechCrunch says it has reached out to the company for comment.

This is not 1789 Capital's first check to the prediction market operator. The fund previously invested $200 million in Polymarket, meaning its total stake now approaches $500 million across two rounds. That scale of commitment from a single investor is notable on its own. It becomes more notable given who is writing the checks and what else that fund has bankrolled.

1789 Capital has a track record of backing contrarian and politically charged ventures. It co-led a Series B round for the Enhanced Games, an event dubbed the "steroid Olympics" by critics, founded by a group of tech industry veterans. The fund's investment thesis appears to favor disruptive, regulation-adjacent businesses, and Polymarket fits that mold closely.

A Regulatory Battle With High Stakes

The timing of this raise matters. Prediction markets are facing an unusually aggressive regulatory push at the state level. At least 20 states are currently engaged in litigation against prediction platforms, according to New York Times reporting, largely centered on sports wagering features offered through these sites. State regulators view sports-related prediction contracts as a form of gambling that falls under their jurisdiction, not federal oversight.

The federal government has taken the opposite position, and forcefully so. The Trump administration has argued that the Commodity Futures Trading Commission should be the sole regulator of the prediction market industry, freezing out state-level gambling authorities entirely. The CFTC has gone further than argument. It has sued at least nine states over their attempts to impose rules on platforms like Polymarket and Kalshi.

State attorneys general are not backing down. A coalition of 44 state AGs recently signed a letter disputing the CFTC's claimed authority over sports-related prediction contracts specifically. That is a near-unanimous rebuke from state law enforcement officials, spanning both political parties, and it signals this fight is far from settled.

Donald Trump Jr. has inserted himself directly into this debate. He recently appeared at an event for conservative state attorneys general, where he described the prediction market industry as already subject to "robust oversight" and argued the sites are properly "overseen by federal officials, not state attorneys general." That is not neutral commentary from a passive investor. It is advocacy from someone with a direct financial stake in the outcome, through a fund that has now committed roughly half a billion dollars to Polymarket.

Key Figures

The numbers here deserve to be stated plainly. $300 million is the new investment from 1789 Capital. $200 million was the fund's prior stake. $1 billion is the reported total size of the current funding round. $500 million, roughly, is 1789 Capital's cumulative exposure to a single prediction market platform. Twenty states are suing prediction sites. Nine states have been sued by the CFTC. Forty-four state attorneys general have signed a letter challenging federal authority over sports prediction contracts.

Each of these figures tells part of the story, but together they describe a business operating in a genuine legal gray zone, backed by an investor whose political connections extend directly into the regulatory apparatus deciding that business's fate. That is an unusual capital structure for a fintech platform, and it is worth weighing carefully.

For investors evaluating exposure to prediction markets, either directly or through adjacent crypto and fintech plays, the regulatory overhang is the dominant variable right now, more than user growth or trading volume. Polymarket's valuation implied by this round, likely in the multiple billions given the $1 billion raise size, assumes continued federal protection from state-level restrictions. If courts side with states on jurisdiction, or if a future administration reverses the CFTC's current posture, that valuation assumption could unwind quickly.

There is also a governance question worth flagging. When a major investor in a regulated or quasi-regulated business is also actively lobbying regulators and appearing at political events to shape the regulatory narrative in that business's favor, the line between investment and influence campaign gets blurry. That is not illegal. It is not even unusual in politically adjacent industries like defense or energy. But it does mean investors should treat regulatory tailwinds here as partly a function of political capital rather than pure legal merit, and political capital can change hands.

Investment Implications

Polymarket's ability to raise at this scale, with backing from a fund connected to the sitting president's family, suggests confidence that federal preemption of state gambling law will hold. That is a real bet, not a settled fact. The 44-state coalition and ongoing litigation in 20 states represent meaningful downside risk that no funding round can eliminate.

For those already holding exposure to prediction markets or crypto-adjacent platforms, the near-term catalyst to watch is how courts rule on CFTC authority versus state jurisdiction over sports contracts. A loss for the federal position would not necessarily kill Polymarket's business, since election and event markets outside sports betting face less direct state pushback. But it would meaningfully narrow the addressable market and could invite copycat litigation into other product lines.

The $1 billion round signals strong investor appetite despite the legal uncertainty. Whether that appetite is justified depends entirely on how the jurisdictional fight resolves over the next 12 to 18 months. Investors should treat this raise as a signal of conviction, not confirmation of a clear regulatory path.